LOS ANGELES, January 20, 2015 /PRNewswire/ --
Gift of Life Michigan is utilizing the CompuMed, Inc. (OTCPink: CMPD) Enterprise Organ Procurement Organization (OPO) Solution to decrease case times and improve donor organ recovery. CompuMed Enterprise OPO includes a cloud-based telemedicine platform to provide real-time access to its Board-Certified specialists for diagnostic exam interpretations and critical care consulting.
With CompuMed Enterprise OPO, Organ Procurement Organizations are able to enhance the recovery of transplantable organs by leveraging services that include serial echocardiogram interpretations, ECG overreads and critical care consulting. CompuMed's on-call specialist coverage for STAT donor cases can save OPOs up to 3-12 hours per case and is available during the day, after hours and weekends.
"As one of the leaders in organ recovery, we very much appreciate the opportunity to collaborate with Gift of Life Michigan. With CompuMed Enterprise OPO, Gift of Life Michigan is able to decrease case times, increase the number of viable donor organs and ultimately save lives," said W. Scott Rombach, CompuMed's President and CEO.
"With the clock ticking and every second counting, we really appreciate the responsiveness and turnaround times CompuMed provides us and we are pleased with the accuracy of their echo interpretations. They have really helped us expedite organ donor management and stay on track with organ allocation goals," said Bruce Nicely, Gift of Life Michigan's Chief Clinical Officer.
CompuMed has a national team of specialists in areas such as cardiology, radiology and pulmonology. Details of CompuMed's Enterprise OPO Solution can be viewed at compumedinc.com.
About CompuMed, Inc.
CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board- Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at www.compumedinc.com .
Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.
CompuMed, Inc. Investor Relations: [email protected] or (310) 258-5000 x117